Download | < Back |
21 Mar 2017 | |
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI(Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for GlaxoSmithKline Pte Ltd | |
View all announcements for GLAXOSMITHKLINE PHARMACEUTICALS LTD. | Source: BSE India |